Cytomegalovirus Enterocolitis secondary to experimental COVID-19 therapy
Sign Up to like & getrecommendations! Published in 2020 at "IDCases"
DOI: 10.1016/j.idcr.2020.e00962
Abstract: The novel coronavirus-2019 (COVID-19) has caused a global pandemic of historical proportions, infecting millions of people worldwide. Due to its high mortality rate and a paucity of clinical data, experimental therapies have been utilized with… read more here.
Keywords: secondary experimental; enterocolitis secondary; covid therapy; covid ... See more keywords